Pausing feeding during blood transfusions for very premature babies
Part of Digestive system, Women’s health & pregnancy clinical trials.
This trial looks at whether it’s safer to temporarily withhold (pause) breast milk or formula feeds around the time of a blood transfusion in very premature babies. It may help reduce gut-related complications like NEC, a serious intestinal problem.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were born very early: less than 30 weeks gestation at birth
- Your parent/guardian agrees to take part in the study
- Before the study blood transfusion, you can receive small amounts of milk/feeds (at least about 15 mL per kg per day)
- Feeding should not be medically unsafe for you (for example, certain major stomach/intestine birth problems)
- You have not had NEC (NEC stage 2 or higher) or SIP before your first study blood transfusion
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how different types of feeding affect the gut of very preterm babies when they receive a blood transfusion. If your baby qualifies, the team will do extra monitoring and ultrasound scans to learn more about gut health during transfusions.
This study compares different ways of feeding very premature babies to see which method helps prevent serious gut problems, reduces the risk of death, and supports brain growth. If your baby is born very early, this research may help find the safest feeding approach.
This trial studies a treatment made from special particles in donor breast milk, given to very early-born babies who are at risk of a serious gut infection called NEC. It aims to see if these particles can help protect their intestines.
This trial tests different ways of transferring blood from the umbilical cord to very premature babies (born at or before 32 weeks) to see if it can prevent complications of prematurity and improve their blood counts. It aims to find the best method for helping these vulnerable newborns.
This study compares two different amounts of platelet transfusions to see which is safer and more effective for premature babies with very low platelet counts. Platelets are tiny cells in the blood that help stop bleeding, so this treatment may reduce the risk of serious bleeding in the brain.
This study uses ultrasound and a light-based sensor to monitor the gut in very premature babies who receive a blood transfusion. The goal is to see if these tools can detect early signs of intestinal injury, which may help prevent serious complications.
Hear when a new Necrotizing Enterocolitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.